American Tech Today
SEE OTHER BRANDS

Hottest science and technology news from the United States

American Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.

Press releases published on April 25, 2025

As the price of Bitcoin (BTC) continues to rise recently, many Bitcoin (BTC) players have started to start Dogecoin (DOGE) in blockchain cloud mining to earn more lucrative returns

As the price of Bitcoin (BTC) continues to rise recently, many Bitcoin (BTC) players have started to start Dogecoin (DOGE) in blockchain cloud mining to earn more lucrative returns

Dublin, California, April 25, 2025 (GLOBE NEWSWIRE) -- It is worth mentioning that Burak Kesmeci, a well-known cryptocurrency analyst, shared an interesting on-chain analysis of the Bitcoin (BTC) market in a new article on the X platform. The analyst …

Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement

Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement

WEXFORD, Pa., April 25, 2025 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq; COEP) (“Coeptis” or the “Company”), a biopharmaceutical and technology company focused on developing innovative cell therapy platforms for cancer, autoimmune and …

Reducto Raises $24.5M Series A Round to Help Enterprises Unlock Unstructured Data

Reducto Raises $24.5M Series A Round to Help Enterprises Unlock Unstructured Data

SAN FRANCISCO, April 25, 2025 (GLOBE NEWSWIRE) -- Reducto, the most accurate ingestion platform for unlocking unstructured data for AI pipelines, announced today that it has raised a $24.5M series A round of funding led by Benchmark, alongside existing …

Syncromune® Inc. to Present Clinical Data from SYNC-T Therapy SV-102 Phase 1 Trial at the American Society for Clinical Oncology Annual Meeting 2025

Syncromune® Inc. to Present Clinical Data from SYNC-T Therapy SV-102 Phase 1 Trial at the American Society for Clinical Oncology Annual Meeting 2025

FORT LAUDERDALE, Fla. and WEST DES MOINES, Iowa, April 25, 2025 (GLOBE NEWSWIRE) -- Syncromune®, Inc., a clinical-stage biopharmaceutical company dedicated to the development of SYNC-T, an in situ platform combination therapy optimized for solid tumor …

Telos Corporation to Announce First Quarter 2025 Financial Results on May 9, 2025

Telos Corporation to Announce First Quarter 2025 Financial Results on May 9, 2025

ASHBURN, Va., April 25, 2025 (GLOBE NEWSWIRE) -- Telos Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced that it will report first quarter …

Cogent Biosciences Presents Four Posters at the American Association for Cancer Research Annual Meeting 2025 and Announces Two New Leaders

Cogent Biosciences Presents Four Posters at the American Association for Cancer Research Annual Meeting 2025 and Announces Two New Leaders

WALTHAM, Mass. and BOULDER, Colo., April 25, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced preclinical data from four …

Enviri Corporation to Participate in Upcoming Investor Conferences

Enviri Corporation to Participate in Upcoming Investor Conferences

PHILADELPHIA, April 25, 2025 (GLOBE NEWSWIRE) -- Enviri Corporation (NYSE: NVRI), a global, market-leading provider of environmental solutions for industrial and specialty waste streams, today announced that Company management will be participating in the …

Codetta Bio Launches Concerto™ System at AACR 2025 and Invites Attendees to Be a Part of “The Opening Concerto”

Codetta Bio Launches Concerto™ System at AACR 2025 and Invites Attendees to Be a Part of “The Opening Concerto”

DURHAM, N.C., April 25, 2025 (GLOBE NEWSWIRE) -- Codetta Bio is proud to announce the official launch of the Concerto™ System, a revolutionary new multi-omics platform, at the American Association for Cancer Research (AACR) Annual Meeting 2025. The …

VYNE Therapeutics Provides Update on VYN202 Program

VYNE Therapeutics Provides Update on VYN202 Program

BRIDGEWATER, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) verbally informed the Company that it placed a clinical hold on the …

Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711

Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711

SAN DIEGO, April 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced that in connection with the …

Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

Vancouver, Canada, April 25, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …

Y-mAbs Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating CD38-SADA Pre-targeted Radioimmunotherapy in Relapsed/Refractory Non-Hodgkin Lymphoma

Y-mAbs Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating CD38-SADA Pre-targeted Radioimmunotherapy in Relapsed/Refractory Non-Hodgkin Lymphoma

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based …

BPGbio Highlights Groundbreaking Data on BPM31510 for Mitochondrial Diseases at the Inaugural Mitochondrial Transplantation and Next Generation Therapeutics Conference

BPGbio Highlights Groundbreaking Data on BPM31510 for Mitochondrial Diseases at the Inaugural Mitochondrial Transplantation and Next Generation Therapeutics Conference

BOSTON, April 25, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a leading biology-first, AI-powered clinical-stage biopharma company focused on mitochondrial biology and protein homeostasis, today announced a poster presentation at the inaugural Mitochondrial …

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Calibre Mining Securityholders Vote FOR the Proposed Arrangement with Equinox Gold

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Calibre Mining Securityholders Vote FOR the Proposed Arrangement with Equinox Gold

Your vote is important, regardless of the number of Calibre shares you hold. Securityholders are encouraged to vote in advance of the deadline on Tuesday, 29 April at 10:00 a.m. (Vancouver time). For assistance in voting, please contact Laurel Hill …

ZenaDrone de ZenaTech obtiene aprobación de la FAA Parte 137 para operaciones agrícolas con drones, abordando un mercado global valorado en $ 6 mil millones que alcanzará los $ 24 mil millones para 2032

ZenaDrone de ZenaTech obtiene aprobación de la FAA Parte 137 para operaciones agrícolas con drones, abordando un mercado global valorado en $ 6 mil millones que alcanzará los $ 24 mil millones para 2032

VANCOUVER, Columbia Británica, April 24, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), una empresa de tecnología especializada en drones de IA (Inteligencia Artificial), Dron como un Servicio (DaaS), soluciones …

Ero Copper Announces Voting Results of Annual General Meeting of Shareholders

Ero Copper Announces Voting Results of Annual General Meeting of Shareholders

VANCOUVER, British Columbia , April 24, 2025 (GLOBE NEWSWIRE) -- Ero Copper Corp. (TSX: ERO, NYSE: ERO) ("Ero" or the “Company”) reported the voting results from its Annual General Meeting of Shareholders held today in Vancouver, British Columbia. A total …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service